口腔鳞状细胞癌的表观遗传学研究现状和进展

doi:10.3969/j.issn.1005-4979.2016.02.001

摘要/Abstract

摘要： 口腔鳞状细胞癌（OSCC）是最常见的口腔颌面部恶性肿瘤之一，但目前对于OSCC的具体发病机制并不十分清楚。当前的研究认为在OSCC发生发展中的基因变化因素主要包括基因突变与表观遗传修饰异常。表观遗传修饰是可遗传、可逆转的生物学行为，主要包括DNA甲基化、组蛋白修饰、非编码RNA调控等。近来研究发现，表观遗传修饰的改变尤其是DNA甲基化对OSCC的发病过程意义重大。对于表观遗传学修饰改变的进一步探索将有助于我们理解 OSCC的发病机制，该机制将为OSCC的诊断、治疗、预后提供一个新的研究思路，并且为新型抗肿瘤药物的研发工作，提供了新的理论基础。

关键词: 口腔鳞状细胞癌； , 表观遗传修饰； , DNA甲基化； , 组蛋白修饰

Abstract: Dysregulation of gene expression is a frequent occurrence in oral squamous cell carcinoma (OSCC). However, accumulating evidence suggests that in contrast to genetics, epigenetic modifications consisting of aberrant DNA methylation, histone modification, and altered expression of miRNAs induce OSCC tumorigenesis and perhaps play more central role in the evolution and progression of this disease. In this article, we provide a comprehensive review of the impact of epigenetics on oral tumorigenesis with a systematic report on DNA methylation, histone modification, and altered expression of miRNAs in the pathogenesis of OSCC.

Key words: oral squamous cell carcinoma, epigenetic mechanisms；DNA methylation；histone modification

中图分类号:

R781.7

张斌. 口腔鳞状细胞癌的表观遗传学研究现状和进展[J]. 《口腔颌面外科杂志》, 2016, 26(2): 77-82.

ZHANG Bin. Recent Advances of the Epigenetics on Oral Squamous Cell Carcinoma Tumorigenesis[J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(2): 77-82.

https://journal06.magtech.org.cn/Jweb_joms/CN/Y2016/V26/I2/77

参考文献

[1] Siegel RL, Miller KD, Jemal A. Cancer statistics[J]. CA Cancer J Clin, 2015, 65(1):5-29.

[2] Lingen MW, Pinto A, Mendes RA, et al. Genetics/epigenetics of oral premalignancy: current status and future research[J]. Oral Dis, 2011, 17(1):7-22.

[3] Bonasio R, Tu S, Reinberg D. Molecular signals of epigenetic states[J]. Science, 2010, 330(6004):612-616.

[4] Costa FF. Epigenomics in cancer management[J]. Cancer Manag Res, 2010, 2:255-265.

[5] lyer LM, Abhiman S, Aravind L. Natural history of eukaryotic DNA methylation systems[J]. Prog Mol Biol Transl Sci, 2011, 101:25-104.

[6] Hassig CA, Schreiber SL. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs[J]. Curr Opin Chem Biol, 1997, l(3):300-308.

[7] Suh N, Blelloch R. Small RNAs in early mammalian development: from gametes to gastrulation[J]. Development, 2011, 138(9):1653-1661.

[8] Hammoud SS, Cairns BR, Jones DA. Epigenetic regulation of colon cancer and intestinal stem cells[J]. Curr Opin Cell Biol, 2013, 25(2):177-183.

[9] Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics[J]. Nat Rev Genet, 2008, 9(6):465-476.

[10] Esteller M. Dormant hypermethylated tumour suppressor genes: questions and answers[J]. J Pathol, 2005, 205(2):172-180.

[11] Milutinovic S, Knox JD, Szyf M. DNA methyltransferase inhibition induces the transcription of the tumor suppressor p21(WAF1/CIP1/sdi1)[J]. J Biol Chem, 2000, 275(9):6353-6359.

[12] Nolan T, Braccini L, Azzalin G, et al. The post-transcriptional gene silencing machinery functions independently of DNA methylation to repress a LINE1-like retrotransposon in Neurospora crassa[J]. Nucleic Acids Res, 2005, 33(5):1564-1573.

[13] Rhee I, Bachman KE, Park BH, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells[J]. Nature, 2002, 416(6880):552-556.

[14] Jones PA , Baylin SB. The fundamental role of epigenetic events in cancer[J]. Nat Rev Genet, 2002, 3(6):415-428.

[15] Mydlarz WK, Hennessey PT, Califano JA. Advances and perspectives in the molecular diagnosis of head and neck cancer[J]. Expert Opin Med Diagn. 2010, 4(1):53-65.

[16] Radhakrishnan R, Kabekkodu S, Satyamoorthy K. DNA hypermethylation as an epigenetic mark for oral cancer diagnosis[J]. J Oral Pathol Med, 2011, 40(9):665-676.

[17] Díez-Pérez R, Campo-Trapero J, Cano-Sánchez J, et al. Methylation in oral cancer and pre-cancerous lesions (Review)[J]. Oncol Rep, 2011, 25(5):1203-1209.

[18] SupieG, Kozomara R, Brankovie-MagieM, et al. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients[J]. Oral Oncol, 2009, 45(12):1051-1057.

[19] de Freitas Cordeiro-Silva M, Oliveira ZF, de Podestá JR, et al. Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma[J]. Mol Biol Rep, 2011, 38(8):5435-5441.

[20] Pannone G, Bufo P, Santoro A, et al. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors[J]. Oncol Rep, 2010, 24(4):1035-1041.

[21] Huang KH, Huang SF, Chen IH, et al. Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma[J]. Clin Cancer Res, 2009, 15(12):4174-4180.

[22] Supic G, Jovic N, Kozomara R, et al. Interaction between the MTHFR C677T polymorphism and alcohol--impact on oral cancer risk and multiple DNA methylation of tumor-related genes[J]. J Dent Res, 2011, 90(1):65-70.

[23] Kozaki K, Imoto I, Mogi S, et al. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer[J]. Cancer Res, 2008, 68(7):2094-2105.

[24] Shaw R. The epigenetics of oral cancer[J]. Int J Oral Maxillofac Surg, 2006, 35(2):101-108.

[25] Mancuso M, Matassa DS, Conte M, et al. H3K4 histonemethylation in oral squamous cell carcinoma[J]. Acta Biochim Pol, 2009, 56(3),405-410.

[26] Balasubramanian A, Subramaniam R，Narayanan V，et al. BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas[J]. Asian Pac J Cancer Prev, 2015, 16(4),1615-1619.

[27] Reddy VR, Annamalai T，Narayanan V，et al. Hypermethylation of promoter region of LATS1-a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India[J]. Asian Pac J Cancer Prev, 2015, 16(4),1599-1603.

[28] Lin HY, Hung SK, Lee MS, et al. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer:an outcome-predicting and treatment-implicating study[J]. Oncotarget, 2015, 6(2):915-934.

[29] Melchers LJ, Clausen MJ, Mastik MF, et al. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma[J]. Epigenetics, 2015, 10(9):850-860.

[30] Jenuwein T, Allis CD.Translating the histone code[J]. Science, 2001, 293(5532):1074-1080.

[31] Strahl BD, Allis CD. The language of covalent histone modifications[J]. Nature, 2000, 403(6765):41-45.

[32] Zentner GE, Henikoff S. Regulation of nucleosome dynamics by histone modifications[J]. Nat Struct Mol Biol, 2013, 20(3):259-266.

[33] Tasoulas J, Giaginis C, Patsouris E, et al. Histone deacetylase inhibitors in oral squamous cell carcinoma treatment[J]. Expert Opin Investig Drugs, 2015, 24(1):69-78.

[34] Sakuma T, Uzawa K, Onda T, et al. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma[J]. Int J Oncol, 2006, 29(1):117-124.

[35] Kiyoshima T, Yoshida H, Wada H, et al. Chemoresistance to concanamycin A1 in human oral squamous cell carcinoma is attenuated by an HDAC inhibitor partly via suppression of Bcl-2 expression[J]. PLoS One, 2013, 8(11):e80998.

[36] Ohta M, Abe A, Ohno F, et al. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines[J]. Oral Oncol, 2013, 49(1):20-26.

[37] Ahn MY, Ahn SG, Yoon JH. Apicidin, a histone deaceylase inhibitor, induces both apoptosis and autophagy in human oral squamous carcinoma cells[J]. Oral Oncol, 2011, 47(11):1032-1038.

[38] Jeon YJ, Ko SM, Cho JH, et al. The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma[J]. Int J Mol Med, 2013, 32(4):860-866.

[39] Hu J, Colburn NH. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding[J]. Mol Cancer Res, 2005, 3(2):100-109.

[40] Miki Y, Mukae S, Murakami M, et al. Butyrate inhibits oral cancer cell proliferation and regulates expression of secretory phospholipase A2-X and COX-2[J]. Anticancer Res, 2007, 27(3B):1493-1502.

[41] Wang A, Zeng R, Huang H. Retinoic acid and sodium butyrate as cell cycle regulators in the treatment of oral squamous carcinoma cells[J]. Oncol Res, 2008, 17(4):175-182.

[42] Murakami J, Asaumi J, Kawai N, et al. Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer[J]. Cancer Chemother Pharmacol, 2005, 56(1):22-28.

[43] Yamamoto D, Shima K, Matsuo K, et al. Ornithine decarboxylase antizyme induces hypomethylation of genome DNA and histone H3 lysine 9 dimethylation (H3K9me2) in human oral cancer cell line[J]. PLoS One, 2010, 5(9):e12554.

[44] Lachner M, Jenuwein T. The many faces of histone lysine methylation[J]. Curr Opin Cell Biol, 2002, 14(3):286-298.

[45] Li J, Huang H, Sun L, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor[J]. Clin Cancer Res, 2009, 15(12):3998-4008.

[46] Liu X, Wang A, Heidbreder CE, et al. MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma[J]. FEBS Lett, 2010, 584(18):4115-4120.

[47] Lu YC, Chang JT, Liao CT, et al. OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4- JNK- TIMP1-MMP signaling pathway[J]. Mol Cancer, 2014, 13:218.

[48] Chang CJ, Hsu CC, Chang CH, et al. Let-7d functions as novel regulator of epithelial- mesenchymal transition and chemoresistant property in oral cancer[J]. Oncol Rep, 2011, 26(4):1003-1010.

[49] Long XB, Sun GB, Hu S, et al. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer[J]. Oncol Rep, 2009, 22(5):1189-1195.

[50] Sasahira T, Kurihara M, Bhawal UK, et al. Downregulationof miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF--A in oral cancer[J]. Br J Cancer, 2012, 107(4):700-706.

[51] Nagata S, Hamada T, Yamada N, et al. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma[J]. Cancer, 2012, 118(17):4298-4308.

[52] Kusumoto T, Hamada T, Yamada N, et al. Comprehensive epigenetic analysis using oral rinse samples: a pilot study[J]. J Oral Maxillofac Surg, 2012, 70(6):1486-1494.

选择文件类型/文献管理软件名称

选择包含的内容